Modern Chinese Medicine Group Co., Ltd. (1643.HK)
HKD 0.34
(-6.94%)
HKD 0.34
(-6.94%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 8.47 Million | 125.78 Million | 57.59 Million | 42.75 Million | 40.24 Million | 77.11 Million |
| Net Income | 68.3 Million | 124.32 Million | 114.22 Million | 90.47 Million | 65.25 Million | 64.5 Million |
| Depreciation & Amortization | 6.44 Million | 5.69 Million | 2.72 Million | 1.83 Million | 1.55 Million | 1.71 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -44.92 Million | 24.05 Million | -25.32 Million | -25.68 Million | -5.54 Million | 25.41 Million |
| Other non-cash items | -901 Thousand | -28.28 Million | -34.02 Million | -23.87 Million | -21.01 Million | -14.52 Million |
| Investing Cash Flow | -4.19 Million | -11.04 Million | -70.04 Million | -408 Thousand | -1.2 Million | -37 Thousand |
| Investments in PPE | -5.09 Million | -11.72 Million | -70.46 Million | -544 Thousand | -2.61 Million | -172 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 906 Thousand | 675 Thousand | 421 Thousand | 136 Thousand | 1.41 Million | 135 Thousand |
| Financing Cash Flow | -326 Thousand | -8.72 Million | 115.75 Million | -5.05 Million | -92.94 Million | - |
| Debt repayment | -321 Thousand | -390 Thousand | -5 Million | -5 Million | -5 Million | - |
| Dividends payments | - | -8.32 Million | - | - | -103.26 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | 147.8 Million | - | - | - |
| Other Financing Activities | -5000.00 | -404 Thousand | -27.04 Million | -51 Thousand | 10.31 Million | - |
| Accounts receivables | -25.17 Million | -6.68 Million | 9.69 Million | -54.24 Million | 973 Thousand | 4.18 Million |
| Accounts payables | - | 6.68 Million | -9.69 Million | 54.24 Million | -973 Thousand | - |
| Inventory | -4.95 Million | 17.18 Million | -24.72 Million | 6.96 Million | -1.92 Million | 14.54 Million |
| Other working capital | -14.78 Million | 6.87 Million | -596 Thousand | -32.65 Million | -3.62 Million | 10.87 Million |
| Cash at beginning of period | 282.25 Million | 176.09 Million | 73.19 Million | 35.89 Million | 89.94 Million | 12.86 Million |
| Cash at end of period | 286.26 Million | 282.25 Million | 176.09 Million | 73.19 Million | 35.89 Million | 89.94 Million |
| Capital Expenditure | -5.09 Million | -11.72 Million | -70.46 Million | -544 Thousand | -2.61 Million | -172 Thousand |
| Effect of forex changes on cash | 52 Thousand | 153 Thousand | -407 Thousand | - | -139 Thousand | - |
| Net cash flow / Change in cash | 4.01 Million | 106.16 Million | 102.9 Million | 37.3 Million | -54.04 Million | 77.07 Million |
| Free Cash Flow | 3.37 Million | 114.06 Million | -12.87 Million | 42.21 Million | 37.62 Million | 76.94 Million |
| Breakdown | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 22.91 Million | 68.3 Million | 31.19 Million | 124.32 Million | 42.54 Million | 60.27 Million |
| Depreciation & Amortization | 3.58 Million | 6.44 Million | 3.53 Million | 5.69 Million | 3.28 Million | 3.34 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -44.92 Million | - | 24.05 Million | - | - |
| Other non-cash items | -14.17 Million | -901 Thousand | -22.69 Million | -28.28 Million | 31.68 Million | 14 Million |
| Investing Cash Flow | 51.07 Thousand | -4.19 Million | -5.55 Million | -11.04 Million | -7.9 Million | -5.25 Million |
| Investments in PPE | 51.07 Thousand | -5.09 Million | -5.55 Million | -11.72 Million | -7.9 Million | -5.25 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | 906 Thousand | - | 675 Thousand | - | - |
| Financing Cash Flow | -53.87 Thousand | -326 Thousand | -292.91 Thousand | -8.72 Million | 565.75 Thousand | -10.34 Million |
| Debt repayment | - | -321 Thousand | - | -390 Thousand | - | - |
| Dividends payments | - | - | - | -8.32 Million | -711.14 Thousand | -10.04 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | -5000.00 | - | -404 Thousand | -145.38 Thousand | - |
| Accounts receivables | - | -25.17 Million | - | -6.68 Million | - | - |
| Accounts payables | - | - | - | 6.68 Million | - | - |
| Inventory | - | -4.95 Million | - | 17.18 Million | - | - |
| Other working capital | - | - | - | 6.87 Million | - | - |
| Cash at beginning of period | 303.73 Million | 282.25 Million | 316.9 Million | 176.09 Million | 259.99 Million | 215.4 Million |
| Cash at end of period | 315.18 Million | 286.26 Million | 303.73 Million | 282.25 Million | 316.9 Million | 259.99 Million |
| Capital Expenditure | 51.07 Thousand | -5.09 Million | -5.55 Million | -11.72 Million | -7.9 Million | -5.25 Million |
| Effect of forex changes on cash | - | 52 Thousand | -12.28 Million | 153 Thousand | -6.7 Million | -10.75 Million |
| Net cash flow / Change in cash | 11.44 Million | 4.01 Million | -13.16 Million | 106.16 Million | 56.9 Million | 44.59 Million |
| Free Cash Flow | 5.21 Million | 3.37 Million | -591.48 Thousand | 114.06 Million | 63.04 Million | 65.68 Million |
688683
XPC
DHC
KDSX
PHR
TRU